ID: ALA120432

Max Phase: Preclinical

Molecular Formula: C28H28ClN5O3

Molecular Weight: 518.02

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(-c2c(OCC[C@@H]3CCN3)c3cc(C(=O)Nc4ccncn4)c(Cl)cc3[nH]c2=O)cc(C)c1C

Standard InChI:  InChI=1S/C28H28ClN5O3/c1-15-10-18(11-16(2)17(15)3)25-26(37-9-6-19-4-8-31-19)21-12-20(22(29)13-23(21)33-28(25)36)27(35)34-24-5-7-30-14-32-24/h5,7,10-14,19,31H,4,6,8-9H2,1-3H3,(H,33,36)(H,30,32,34,35)/t19-/m0/s1

Standard InChI Key:  XESORVDKNANWAB-IBGZPJMESA-N

Associated Targets(Human)

Gonadotropin-releasing hormone receptor 3398 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gonadotropin-releasing hormone receptor 1829 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Gonadotropin-releasing hormone receptor 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 518.02Molecular Weight (Monoisotopic): 517.1881AlogP: 4.95#Rotatable Bonds: 7
Polar Surface Area: 109.00Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.84CX Basic pKa: 10.59CX LogP: 3.96CX LogD: 1.24
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.32Np Likeness Score: -0.80

References

1. Guo Z, Chen Y, Wu D, Zhu YF, Struthers RS, Saunders J, Xie Q, Chen C..  (2003)  Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists.,  13  (20): [PMID:14505682] [10.1016/s0960-894x(03)00746-7]
2. DeVita RJ, Walsh TF, Young JR, Jiang J, Ujjainwalla F, Toupence RB, Parikh M, Huang SX, Fair JA, Goulet MT, Wyvratt MJ, Lo JL, Ren N, Yudkovitz JB, Yang YT, Cheng K, Cui J, Mount G, Rohrer SP, Schaeffer JM, Rhodes L, Drisko JE, McGowan E, MacIntyre DE, Vincent S, Carlin JR, Cameron J, Smith RG..  (2001)  A potent, nonpeptidyl 1H-quinolone antagonist for the gonadotropin-releasing hormone receptor.,  44  (6): [PMID:11300873] [10.1021/jm000275p]
3. Tucci FC, Zhu YF, Struthers RS, Guo Z, Gross TD, Rowbottom MW, Acevedo O, Gao Y, Saunders J, Xie Q, Reinhart GJ, Liu XJ, Ling N, Bonneville AK, Chen T, Bozigian H, Chen C..  (2005)  3-[(2R)-Amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3-methoxyphenyl)- 6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterization.,  48  (4): [PMID:15715483] [10.1021/jm049218c]
4. DeVita RJ, Parikh M, Jiang J, Fair JA, Young JR, Walsh TF, Goulet MT, Lo JL, Ren N, Yudkovitz JB, Cui J, Yang YT, Cheng K, Rohrer SP, Wyvratt MJ..  (2004)  Identification of neutral 4-O-alkyl quinolone nonpeptide GnRH receptor antagonists.,  14  (22): [PMID:15482932] [10.1016/j.bmcl.2004.08.056]
5. Betz SF, Zhu YF, Chen C, Struthers RS..  (2008)  Non-peptide gonadotropin-releasing hormone receptor antagonists.,  51  (12): [PMID:18419112] [10.1021/jm701249f]

Source